课题基金 / 基金详情

Factoring Clinical Biopsy Expression Data into Cell-type Specific Signatures

Factoring Clinical Biopsy Expression Data into Cell-type Specific Signatures
将临床活检表达数据分解为细胞类型特异性特征
批准号:
7593407
负责人:
Vipul Periwal
金额:
$4.91万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Vipul Periwal的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Any given normal sample has some set of cell types, say N. So any given sample tissue array measurement is a convex linear combination of N cell type specific signatures. Different biopsy samples differ in their linear combination coefficients and also genotypic differences between subjects. The presumption in this analysis is that the genotypic differences are not significant between normal samples. (The entire analysis is pointless if the genotypic differences overwhelm the similarities attributable to abstract cell types.) So there is a column-wise convex matrix MS such that for every gene g the matrix Sg = BgMS where Bg is the cell type expression vector for g and Sg is the vector of expression data for g for all the subjects. The matrix MS is independent of the gene and therefore this is an overdetermined system, with a solution to be determined by optimization. The columns of MS depend only on the corresponding subjects. Having found an overall consistent MS matrix, we can deduce B for all genes. In reality we do not know N so we have to do model comparison for the choice of N. We modified the Non-negative Matrix Factorization algorithm due to Lee and Seung by adding a step where the matrix MS is made convex prior to the recursion step. We stopped the algorithm when updates did not materially change the matrix distance between Sg and BgMS. We showed that our algorithm is noise tolerant, giving reasonable results even with 50% noise. We applied a Minimum Description Length Criterion to determine the correct value of N, and found that on test data up to 40% noise added, we can still determine the correct value of N. We have also tested the algorithm for robustness against varying subject number and robustness against varying the number of genes measured. Our goal is now to validate our methods by applying our algorithm to clinical data and comparing our results to a pathologists report. Can one associate cancer genotypes with the exclusive-or appearance of specific extreme points? Can one use this approach for other decomposition problems?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adipocyte development and insulin resistance
Single Cell Data Analysis Algorithms
Liver regeneration after partial hepatectomy
Adipocyte development and insulin resistance
海外基金